Bioventus BVS International Segment — Adjusted selling expense

Similar metrics at other companies

SIGInternational segment — Selling, General and Administrative Expense

$29.9M+13.7%

BBYInternational Segment — Adjusted SG&A

$143M+4.4%

CRIInternational — Selling expenses

$28.15M+16.1%

GISInternational — Selling, general, and administrative expenses

$136M-2.6%

QUADInternational — Selling, general and administrative expenses

$3.7M-36.2%

CACIInternational — Indirect costs and selling expenses

$29.66M+22.3%

Questions, answered.

What is Bioventus's international segment — adjusted selling expense?

Bioventus (BVS) reported international segment — adjusted selling expense of $3.32M in Q1 2026.

How has Bioventus's international segment — adjusted selling expense changed year-over-year?

Bioventus's international segment — adjusted selling expense increased by 3.8% year-over-year, from $3.2M to $3.32M.

What is the long-term trend for Bioventus's international segment — adjusted selling expense?

Over 3 years (2022 to 2025), Bioventus's international segment — adjusted selling expense has grown at a 4.0% compound annual growth rate (CAGR), from $11.29M to $12.69M.

What does international segment — adjusted selling expense mean?

Captures the adjusted costs incurred by the sales force and distribution teams dedicated to the international segment. It provides insight into the investment required to maintain and expand market share in foreign territories.